期刊文献+

氯氮平与氟伏沙明合并治疗精神分裂症的研究

Study of combining fluvoxamine and clozapine to treat schizophrenia
下载PDF
导出
摘要 目的研究氯氮平与氟伏沙明合并治疗精神分裂症时的疗效及副作用,为临床更加合理的用药提供依据。方法选取符合CCMD-3诊断标准的,有需要合并应用氯伏沙明的症状的精神分裂症病人30例。单一应用氯氮平,逐渐调整剂量到200~250mg/D,稳定一周后于清晨6时采取患者肘静脉血测定血浆胰岛素、泌乳素水平。并于当日加用氟伏沙明50mg/D。在合并用药后的第4周清晨6时采取患者肘静脉血测定胰岛素、泌乳素水平。合并用药前后测定空腹血糖、血脂、肝功能、心电图。结果合并用药前和合并用药第四周胰岛素、泌乳素异常人数之间无显著差异。合并用药前后空腹血糖异常、心电图异常(除心率)人数无显著差异。合并用药前后肝功能异常、血脂异常、心率异常人数有显著增多。结论建议合并用药时在动态监测氯氮平浓度的情况下结合临床表现及时调整药物用量。合并用药后肝功能异常、心率异常、血脂异常人数有增加,程度较轻不影响治疗。 Objective To study the effect and deleterious effects during combining fluvoxamine and clozapine in treatment of schizophrenia, to be more reasonably using drugs in future. Methods We choosed 30 schizophrenic patients which were diagnosed with the 3rd edition of Chinese classification and diagnostic criteria for mental disorders (CCMD-3) and need using anti-depressive drug. Clozapine was used to 200-250mg/D, one week later at 6 we took the elbow vein blood 5ml to determined plasma insulin, prolactin level. Then we used fluvoxamine 50 mg/D to these patients that evening, At the 4th week at 6 we took the elbow vein blood 5ml to determine plasma insulin, prolactin level Before and after combing fluvoxamine and clozapine we detected blood glucose, blood lipid, liver function, ECG. Results The population that the insulin, prolactin, blood sugar exceeded the high level hadn't significantly distinction before and after combining fluvoxamine and clozapine. The population of EKG (heart rate free) abnormal hadn't significantly distinction before and after combining fluvoxamine and clozapine. The population that liver function, blood lipid, heart rate exceeded the high level had significantly distinction before and after combining fluvoxamine and clozapine. Conclusion We suggest adjusting clozapine quantity according to the plasma clozapine level and clinical symptom after combing fluvoxamine and clozapine. The population that liver function, heart rate, blood lipid exceeded the high level had significantly distinction after combining fluvoxamine and clozapine, but the abnormal wasn't severe and didn't affect treatment.
出处 《海南医学》 CAS 2008年第2期21-23,共3页 Hainan Medical Journal
基金 南京市卫生局(YKK0453)
关键词 氯氮平 氟伏沙明 精神分裂症 胰岛素 泌乳素 血糖 血脂 肝功能 心电图 Clozapine Fluvoxamine Schizophrenia Insulin Prolactin blood glucose blood lipid liver function ECG
  • 相关文献

参考文献8

  • 1Lu ML, Lane HY, Chen KP et al. Fluvoxamine reduces the clozapine dosage needed in refractory schizophrenic patients [J]. Clin Psychopharmacol, 2000,61:594-9.
  • 2Hiemke C, Peled A, Jabarin M et al. Fluvoxamine augmentation of olanzapine in chronic schizophrenia: pharmacokinetic interactions and clinical effects [J].Clin Psychopharmacol, 2002,22:502-6.
  • 3Spina E, Avenoso A,Facciola G et al. Plasma concentrations of risperidone and 9-hydroxyrisperidone during combined treatment with paroxetine. Ther Drug Monit, 2001, 23:223-7.
  • 4赵业华,方竟红,王尚宏,安成革,马迅,李洪星.奎硫平与氯氮平治疗精神分裂症对照研究[J].临床精神医学杂志,2005,15(4):231-232. 被引量:6
  • 5Centorrino F, Baldessarini R J, Frankenburg FR et al. Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors. Am J Sychiatry, 1996,153:820--7.
  • 6奚巍.氯氮平与2型糖尿病[J].中华精神科杂志,2004,37(2):124-125. 被引量:9
  • 7刘素芳,魏平,王世贵,王东平,王云,马慧娟,贾福军.不同剂量氯氮平与精神分裂症患者血脂、血糖代谢的对照研究[J].中华精神科杂志,2005,38(2):82-85. 被引量:31
  • 8司天梅,舒良,于欣,马崔,王高华,白培深,刘协和,纪丽萍,师建国,陈宪生,梅其一,栗克清,张鸿燕,马弘.10省市抗精神病药使用现况的调查[J].中华精神科杂志,2004,37(3):152-155. 被引量:95

二级参考文献31

  • 1周荣山,戴兴海.奎硫平与氯氮平治疗精神分裂症的比较研究[J].上海精神医学,2003,15(4):215-217. 被引量:22
  • 2刘燕,李华芳,王慧芳,王克勋,高哲石,顾牛范.氯氮平、利培酮对精神分裂症病人血糖-胰岛素稳态的影响及相关因素分析[J].上海精神医学,2003,15(5):257-259. 被引量:33
  • 3肖春兰,周天骍,张少平,陈银娣,丛志军,彭伟君,刘仁申,薛玲妹,范幼珠.氯氮平与利培酮对精神病患者糖代谢影响的对照研究[J].上海精神医学,2002,14(4):201-203. 被引量:19
  • 4Small JG,Hirsch SR,Arvantis LA,et al.Quetiapine in patients with schizophrenia,a high and low-dose double-blind comparison with placebo[J].Arch Gen Psychiatry,1997,54:549.
  • 5Widen P,Mcelrop SL,Griffin RA,et al.Quetiapine in the teatment resistant chronic schizophrenia:a randomized double-blind study[J].J Clin Psychiatry,1997,58:63.
  • 6Arvanitis LA,Kandel ER.Quetiapine in the treatment of schizophrenia patient[J].Biol Psychiatry,1997,42:233.
  • 7Chakos M, Lieberman J, Hoffman E, et al. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Am J Psychiatry, 2001, 158:518-526.
  • 8Kane JM, Marder SR, Schooler NR, et al. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison. Arch Gen Psychiatry, 2001, 58:965-972.
  • 9Bhana N, Foster RH, Olney R,et al. Olanzapine: an updated review of its use in the management of schizophrenia. Drugs, 2001, 61:111-161.
  • 10Love RC, Nelson MW. Pharmacology and clinical experience with risperidone. Expert Opin Pharmacother, 2000, 1:1441-1453.

共引文献134

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部